Doctors and Human Patients

Our cancer treatments for human patients using CV247Therapy are designed to manage their symptoms and possible side effects, by controlling the anti-tumour effects of this therapy, and to manage and improve the patients’ quality of life. Human patients have been benefiting from these treatments for many years, and in some cases go on to lead comparatively normal lives.

CV247Therapy cancer therapy is a combination product comprising of Sodium Salicylate, Copper Gluconate, Manganese Gluconate and Ascorbic Acid (Vitamin C) taken in the form of a single tablet. The product was conceived and initially developed by Mr John Carter, veterinary surgeon, who also advocated that in combination with the therapy a patient also followed an organic diet.

There have been a number of formal studies on the use of the product as a cancer therapy for humans. The first of these was a Phase II study, where 37 patients with progressive malignancy were put under analysis by Dr Robert Thomas (Consultant Oncologist at Bedford Hospital and Addenbrokes Hospital). Dr Robert Thomas also undertook a study of 110 patients with progressive prostate cancer over three years. In addition to this, a Phase II study of 36 patients at a private clinic in Harrow, Middlesex was completed by Dr Ros Taylor (Hospice of St Francis, Berkhamstead).

The studies on animals and humans have shown the anti-tumour effect of the therapy, as well as its beneficial effect on the patients’ quality of life. They also showed that the therapy has few adverse side effects.

We recommend that in all cases you should seek Medical Help before taking any medicine and refrain from any form of self-diagnosis.

Please contact us for more information on the availability of our cancer products for dog owners and human patients.

All enquiries are treated in strict confidence